Although generic medicines are used extensively in Nigeria information from community pharmacists about these drugs are scanty and therefore inadequate. This is why this study has been designed to bridge the knowledge gap, attitudes, as well as the perception and practice of community pharmacists about generic medicines in Nigeria.
Method
A questionnaire-guided cross-sectional survey was used to collect data from 380 community pharmacists who were randomly selected from community pharmacies between April and June 2019 in Southwestern Nigeria. Data generated in the course of this study was analysed with the Statistical Package for Social Sciences version 18. Descriptive statistics were used to summarize data. Chi-square was used to test proportions and to determine associations between categorical variables. Pearson’s Correlation Coefficient was used to determine correlation between dependent variables.
Result
Mean knowledge score of community pharmacists about generic medicines(GM) was 5.6 ± 2.9 out of a total maximum score of 10. Results showed that 47.9% of respondents had poor knowledge, 27.6% average knowledge and 24.5% good knowledge about GM. Knowledge was significantly associated (p = .000) with all demographic characteristics except professional qualifications. A majority (89%) of the respondents were of the view that patients need more explanations when GMs are dispensed to them. In addition, 90.3% of the respondents were of the opinion that GM will improve access to medicine because they are cheaper and easily affordable. About 93% practice generic substitution without consulting prescribing physicians. Furthermore, 85% of the respondents claim they stock mainly GMs.
Conclusion
Community pharmacists in Nigeria had a positive attitude, perception and practice about GM, but exhibited sub-optimal knowledge in understanding issues concerning generic medicines. It is concluded that there is the need for continuous training and education to enhance professional knowledge of pharmacists in the area of GM substitution.
WajidSAi-ArifiMNAiHA, et al.
Knowledge and perception of community pharmacists towards generic medicines in Saudi Arabia. Biomed Res2015;
26: 800–806.
5.
OnwujekweOEUzochukwuBSObikezeEN, et al.
Investigating determinants of out-of-pocket spending and strategies of coping with payments of healthcare in southeast Nigeria. BMC Health Serv Res2010;
10: 67.
6.
EwelukwaOOnokaCOnwujekweO.Viewing healthcare expenditures, payment and coping mechanisms with an equity lens in Nigeria. BMC Health Serv Res2013;
13: 87.
7.
OnwujekweOHansonKIchokuH, et al.
Financing incidence analysis of household out-of-pocket spending for healthcare: getting more health for money in Nigeria?Int J Health Plann Manage2014;
29: 174–185.
8.
OnahMNGovenderV.Out-of-Pocket payments, health care access and utilization in South–Eastern Nigeria: a gender perspective. PLoS One2014;
9: e93887.
9.
CameronAMantel-TeeuwisseAKLeufkensHG, et al.
Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved? Value in health. J Inter Soc Pharmacoeconomics and Outcomes Res2012;
15: 664–673.
10.
GodmanBWettermarkBvan WoerkomM, et al.
Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications. Front Pharmacol2014;
5: 106.
11.
GodmanBBishopIFinlaysonAE, et al.
Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other counties. Expert Rev Pharmacoecon Outcomes Res2013;
13: 469–482.
12.
WHO. The role of the pharmacist in the healthcare system.
Geneva:
WHO, 2019.
13.
WHO. Health manpower requirements for the achievement of health for all by year 2000 through Primary Health Care. Report of WHO Expert Committee, World Health Organization Technical Report Series No 717. 1985.
14.
AwaisuAKheirNIzhimM, et al.
Knowledge, attitude, and practices of community pharmacists on generic medicines in Qatar. Int J Clin Pharm2014;
36: 394–404.
15.
WajidSAl-ArifiMAl-NomayH.Knowledge and perception of community pharmacists towards generic medicines in Saudi Arabia. Biomed Res2015;
26: 800–806.
16.
DrozdowskaAHermanowskiT.Exploring factors underlying the attitude of community pharmacists to generic substitutions: a nationwide study from Poland. Int J Clin Pharm2016;
38: 162–170.
17.
BeshirBNOumerSMMiftahSB.Assessment of knowledge, attitude and practice among pharmacy professionals towards generic medicines in Addis Ababa. Journal of Generic Medicines2019; 15(4): 185–192. https://doi.org/10.1177/1741134319875764
18.
HaqueM.Generic medicine and prescribing: a quick assessment. Adv Hum Biol2017;
7: 101–108.
19.
DuerdenMGHughesDA.Generic and therapeutic substitution in the UK: are they a good thing?Br J Clin Pharmacol2010;
70: 335–341.
20.
DylstPVultoAGodmanB, et al.
Generic medicines: solutions for a sustainable drug market?.Appl Health Econ Health Policy2013;
11: 437–443. 2013
21.
ChuaGNHassaliMAShafieAA, et al.
A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the Northern state of Malaysia. Health Policy2010;
95: 229–235.
22.
HassaliMAAlrasheedyAAMcLachlanA, et al.
The experiences of implementing generic medicine policy in eight countries. A review and recommendations for a successful promotion of generic use. Saudi Pharm Soc2014;
22: 491–503.
23.
OyetundeOOAinaBATayoF.Impact of generic substitution practice on care of diabetic patients.Int J Clin Pharm2014;
36: 623–629.
24.
Federal Ministry of Health (FMoH). Access to and rational use of medicines at the house-hold level, 2010.apps.who.int/medicinedocs/documents/s16887e/pdf (accessed 12 April 2020).
25.
Federal Ministry of Health (2010-2011) Nigeria, www.fmh.gov.ng (accessed 12 April 2020).
26.
Federal Ministry of Health. Standard treatment guidelines.
Abuja,
Nigeria: Author, 2008.
27.
TamunoIFadareJO.Drug prescription pattern in a Nigerian tertiary hospital. Trop J Pharm Res2012;
11: 146–152.
28.
BabalolaCPAdebayoASOmotosoA, et al.
Comparative bioavailability study of a new quinine suppository and oral quinine in healthy volunteers. Trop J Pharm Res2004;
3: 291–297.
29.
FernerRELenneyWMarriotJF.Controversy over generic substitution. Bmj2010;
340: c2548.
30.
AutaABalaETShalkurD.Generic medicine substitution: a cross-sectional survey of the perception of pharmacists in North-Central Nigeria. Med Princ Pract2014;
23: 53–58.
31.
AdebayoETHussainNA.Pattern of prescription drug use in Nigerian army hospitals. Ann Afr Med Med2010;
9: 152–158.
32.
FadareJOAdeotiAODesaluOO, et al.
The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians. Expert Rev Pharmacoeconomics Outcomes Rev2016;
16: 639–650.
33.
Federal Republic of Nigeria-IHSN Survey Catalog2010, Abuja, Nigeria.
34.
Pharmacists Council of Nigeria. List of Registered Community Pharmacies in Nigeria, www.pcn.gov.ng (2018, accessed 12 June 2019).
IsraelGD. Determining sample size. Program Evaluation and Organisational Development, IFAS, University of Florida. PEOD-6, http://edis.ifas.ufl.edu (2013, accessed 11 September 2019).
37.
OluwadiyaK. Getting to know SPSS with Endnote, PubMed and Hinari Supplements. 3rd ed. Nigeria: Cedar Publications,Inc., 2013, p.108.
38.
LovelaceMBrickmanP.Research methods. Best practices for measuring students’ attitudes toward learning science. CBE Life Sci Educ2013;
12: 606–617.
39.
BallalaKRaoCRChaudharyAS, et al.
Knowledge, attitude and practices regarding generic medicines and its usage: a community-based study. Int J Community Med Public Health2019;
6: 2182–2188.
40.
ShrainNYTahaTAASweilehWM, et al.
Knowledge, attitudes and practices of community pharmacists on generic medicines: a cross-sectional study. BMC Health Services Res2017;
17: 847.
41.
AlkhuzaeeFSAlmalkiHMAttarAY, et al.
Evaluating community pharmacists perspectives and practices concerning generic medicines substitution in Saudi Arabia. Health Policy2016;
120: 1412–1419.
42.
BashaarMHassaliMASaleemF.Community pharmacists’ attitudes toward the quality and price of locally manufactured generic medicines in Kabul, Afghanistan. J Pharm Policy Pract2015;
8: 16.
43.
JamshedSQHassaliMAAAShafieZ-U-D, et al.Knowledge perception and attitude of community pharmacists towards generic medicines in Karachi, Pakistan: a qualitative insight. Trop J Pharm Res2010;
9(4): 409–415.
44.
ChongCPHassaliMBahariMB.A pilot study of generic medicine substitution practice among community pharmacists in the state of Penang, Malaysia. Pharmacoepidemiol Drug Saf2008;
17: 82–89.
45.
EL-DahiyatFAKayyaliR.Community pharmacists’ perceptions towards generic medicines and their opinions on future generic substitution policy implementation: a descriptive study from Jordan. J Gen Med2018;
10: 97–104.
46.
Al HussainiMAlsaffarNAbdulraheemA.Exploring community pharmacists’ knowledge, perception and experiences towards branded and generic medicines in Kuwait: highlighting the role of pharmacist. Bull Fac Pharm, Cairo University2018;
56: 109–114.
47.
BlackG.Generic substitution and the consumer protection act: a pharmacist’s perspective. SA Pharm J2013;
80: 35–38.
48.
MertenJAShapiroJFGulbisAM, et al.
Utilization of collaborative practice agreements between physicians and pharmacists as a mechanism to increase capacity to care for hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant2013;
19: 509–518.
